Bausch & Lomb (BLCO) Research & Development (2021 - 2026)
Bausch & Lomb (BLCO) posted Research & Development of $101.0 million for Q1 2026, up 7.45% on a QoQ basis from $94.0 million in Q4 2025, and up 17.44% year-over-year from $86.0 million in Q1 2025.
Bausch & Lomb (BLCO) Research & Development (2021 - 2026) Analysis & Trends
Bausch & Lomb's Research & Development history runs 6 years deep, the most recent figure standing at $101.0 million for Q1 2026.
- Quarterly Research & Development rose 17.44% year-over-year to $101.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $386.0 million (up 11.24% YoY) and the FY2025 annual result came in at $371.0 million, up 8.16% from the prior year.
- Research & Development was $101.0 million for Q1 2026 at Bausch & Lomb, up from $94.0 million in the prior quarter.
- Across five years, Research & Development topped out at $101.0 million in Q1 2026 and bottomed at $75.0 million in Q2 2022.
- A 5-year average of $85.1 million and a median of $84.0 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development gained 22.22% — and 2024, when it decreased 1.18%.
- Bausch & Lomb's Research & Development stood at $78.0 million in 2022, then increased by 2.56% to $80.0 million in 2023, then grew by 16.25% to $93.0 million in 2024, then grew by 1.08% to $94.0 million in 2025, then rose by 7.45% to $101.0 million in 2026.
- Business Quant data shows BLCO's Research & Development at $101.0 million in Q1 2026, $94.0 million in Q4 2025, and $95.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 33,163,703.85 Bn | 33,163,702.19 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 119.67 Bn | 114.45 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 43.92 Bn | 43.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 31.71 Bn | 29.47 Bn | 1.84 Bn | - |
| 5 | Resmed | 28.46 Bn | 26.80 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 23.80 Bn | 23.28 Bn | 296.40 Mn | 15.80 Mn |
| 7 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.63 Bn | 13.06 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 11.94 Bn | 10.88 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Bausch & Lomb | 5.77 Bn | 5.49 Bn | 973.00 Mn | 101.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.00 Mn |
| Dec 31, 2025 | 94.00 Mn |
| Sep 30, 2025 | 95.00 Mn |
| Jun 30, 2025 | 96.00 Mn |
| Mar 31, 2025 | 86.00 Mn |
| Dec 31, 2024 | 93.00 Mn |
| Sep 30, 2024 | 84.00 Mn |
| Jun 30, 2024 | 84.00 Mn |
| Mar 31, 2024 | 82.00 Mn |
| Dec 31, 2023 | 80.00 Mn |
| Sep 30, 2023 | 82.00 Mn |
| Jun 30, 2023 | 85.00 Mn |
| Mar 31, 2023 | 77.00 Mn |
| Dec 31, 2022 | 78.00 Mn |
| Sep 30, 2022 | 77.00 Mn |
| Jun 30, 2022 | 75.00 Mn |
| Mar 31, 2022 | 77.00 Mn |
| Dec 31, 2021 | 70.00 Mn |
| Sep 30, 2021 | 63.00 Mn |
| Jun 30, 2021 | 71.00 Mn |